Telix Pharmaceuticals Ltd
ASX:TLX

Watchlist Manager
Telix Pharmaceuticals Ltd Logo
Telix Pharmaceuticals Ltd
ASX:TLX
Watchlist
Price: 18.4 AUD -2.8%
Market Cap: 6.2B AUD

Wall Street
Price Targets

TLX Price Targets Summary
Telix Pharmaceuticals Ltd

Wall Street analysts forecast TLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLX is 32.98 AUD with a low forecast of 25.25 AUD and a high forecast of 37.8 AUD.

Lowest
Price Target
25.25 AUD
37% Upside
Average
Price Target
32.98 AUD
79% Upside
Highest
Price Target
37.8 AUD
105% Upside
Telix Pharmaceuticals Ltd Competitors:
Price Targets
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
2% Upside
AZT
Arcticzymes Technologies ASA
2% Downside
ARX
Aroa Biosurgery Ltd
31% Upside
ALT
Altimmune Inc
447% Upside
OPK
OPKO Health Inc
186% Upside
TH
Theratechnologies Inc
25% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
23% Upside
NTRA
Natera Inc
23% Upside

Revenue
Forecast

Revenue Estimate
Telix Pharmaceuticals Ltd

For the last 6 years the compound annual growth rate for Telix Pharmaceuticals Ltd's revenue is 299%. The projected CAGR for the next 3 years is 33%.

299%
Past Growth
33%
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Telix Pharmaceuticals Ltd

The compound annual growth rate of Telix Pharmaceuticals Ltd's operating income for the next 3 years is 88%.

N/A
Past Growth
88%
Estimated Growth
Estimates Accuracy
19%
Average Beat

Net Income
Forecast

Net Income Estimate
Telix Pharmaceuticals Ltd

The compound annual growth rate of Telix Pharmaceuticals Ltd's net income for the next 3 years is 83%.

N/A
Past Growth
83%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TLX's stock price target?
Price Target
32.98 AUD

According to Wall Street analysts, the average 1-year price target for TLX is 32.98 AUD with a low forecast of 25.25 AUD and a high forecast of 37.8 AUD.

What is Telix Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
33%

For the last 6 years the compound annual growth rate for Telix Pharmaceuticals Ltd's revenue is 299%. The projected CAGR for the next 3 years is 33%.

What is Telix Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
88%

The compound annual growth rate of Telix Pharmaceuticals Ltd's operating income for the next 3 years is 88%.

What is Telix Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
83%

The compound annual growth rate of Telix Pharmaceuticals Ltd's net income for the next 3 years is 83%.

Back to Top